Improvement of lymphangioleiomyomatosis following successful tofacitinib treatment for refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome

二维码有效期 120s

摘要To the Editor:Lymphangioleiomyomatosis (LAM) is a rare multi-systemic disease that predominantly affects women and is associated with cystic lung destruction,chylous fluid accumulation,and abdominal tumors.[1] The lung function of LAM patients declines at two to four or more times faster rates than the typical age-related decline.

作者单位 School of Clinical Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China ^[1] Department of Traditional Chinese Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College Hospital, Beijing 100730, China ^[2] Department of Respiratory and Critical Care Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College Hospital, Beijing 100730, China ^[3] Department of Radiology, Chinese Academy of Medical Sciences & Peking Union Medical College Hospital, Beijing 100730, China ^[4]

栏目名称 Correspondence

DOI 10.1097/CM9.0000000000000441

发布时间 2019-11-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交